Jenburkt Pharmaceuticals Ltd

NEW
BOM:524731 (India)  
₹ 1,090.75 +12.75 (+1.18%) Aug 3
13.42
P/B:
2.36
Market Cap:
₹ 4.81B ($ 50.50M)
Enterprise V:
₹ 4.30B ($ 45.14M)
Volume:
1.66K
Avg Vol (2M):
1.38K
Trade In:

Business Description

Description
Jenburkt Pharmaceuticals Ltd is engaged in the manufacturing, producing, developing, and marketing of pharmaceutical formulations. The company operates in one segment - pharmaceutical formulations. The company generates key revenue from the local market.
Name Current Vs Industry Vs History
Cash-To-Debt
21.51
Equity-to-Asset
0.87
Debt-to-Equity
0.01
Debt-to-EBITDA
0.05
Interest Coverage
87.95
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
11.42
Distress
Grey
Safe
Beneish M-Score
-2.18
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
61.62
9-Day RSI
52.82
14-Day RSI
49.13
3-1 Month Momentum %
6.9
6-1 Month Momentum %
1.07
12-1 Month Momentum %
-12.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
4.11
Quick Ratio
3.52
Cash Ratio
2.31
Days Inventory
123.03
Days Sales Outstanding
48.92
Days Payable
97.09

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield %
1.65
Dividend Payout Ratio
0.21
3-Year Dividend Growth Rate
14.5
Forward Dividend Yield %
1.9
5-Year Yield-on-Cost %
1.65
Shareholder Yield %
1.91

Jenburkt Pharmaceuticals Ltd Filings

Filing Date Document Date Form
No Filing Data

Jenburkt Pharmaceuticals Ltd Stock Events

Financials Calendars
Event Date Price (₹)
INR 20.700000 Cash Dividend 2026-08-28 In 24 days
INR 18.000000 Cash Dividend 2025-07-11 1,385.70 (-1.02%)
Show
Entries

Press Release

Subject Date
No Press Release

Articles on Jenburkt Pharmaceuticals Ltd

No articles.